MoneyWorks4Me

GlaxoSmithKline Pharmaceuticals informs about outcome of schedule of analyst meet

06 Aug 2024 Evaluate

Pursuant to Regulation 30 read with Part A of Schedule Ill of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, GlaxoSmithKline Pharmaceuticals has informed that the recording is uploaded at https://indiapharma.gsk.com/en-in/investors/analyst-meets/.

The above information is a part of company’s filings submitted to BSE.


Peers
Company Name CMP
Sun Pharma. Inds. 1854.15
Dr. Reddys Labs. 1147.70
Cipla 1360.10
Lupin 2046.00
Zydus Lifesciences 1110.00
View more..